XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2022
Apr. 30, 2022
Jul. 31, 2021
Apr. 30, 2021
Jul. 31, 2022
Jul. 31, 2021
Jan. 31, 2022
Operating activities:              
Net loss $ (19,991) $ (25,839) $ (27,592) $ (17,631) $ (45,830) $ (45,223) $ (93,259)
Adjustments to reconcile net loss to net cash provided by operating activities:              
Depreciation and amortization expense         8,702 7,933  
Bad debt expense         491 909  
Stock-based compensation expense         34,168 35,000  
Amortization of operating lease right-of-use assets         4,547 4,619  
Other, net         975 371  
Changes in operating assets and liabilities:              
Accounts receivable         45,808 37,618  
Prepaid expenses and other current assets         (4,716) 1,681  
Costs to obtain revenue contracts         7,583 (8,442)  
Other long term assets         956 15  
Accounts payable, accrued expenses and other current liabilities         242 (711)  
Unearned revenue         (54,154) (26,337)  
Operating lease liabilities         (5,991) (5,634)  
Other long term liabilities         (86) 650  
Net cash (used in) provided by operating activities         (7,305) 2,449  
Investing activities:              
Capital expenditures         (3,875) (10,555)  
Net cash used in investing activities         (3,875) (10,555)  
Financing activities:              
Proceeds from exercise of stock options         525 14,439  
Repurchase of common stock         (58,722) 0  
Payments of deferred financing costs         (283) (263)  
Proceeds, net from employee stock purchase plan withholdings         1,912 3,409  
Net cash (used in) provided by financing activities         (56,568) 17,585  
Effect of exchange rate changes on cash and cash equivalents         (5,556) 600  
Net (decrease) increase in cash and cash equivalents         (73,304) 10,079  
Cash and cash equivalents at beginning of period   $ 261,210   $ 230,411 261,210 230,411 230,411
Cash and cash equivalents at end of period $ 187,906   $ 240,490   $ 187,906 $ 240,490 $ 261,210